What enterprise buyers need before they'll rely on your agent
Your agent works. You have a demo that proves it, a few customers who love it, and metrics that look good in a deck. Then a serious enterprise buyer asks to see your failure rate over the last ninety days, and the deal goes quiet.
This is the pattern that founders shipping agent products run into as they move from early adopters into procurement-stage conversations. The demo was enough to get in the room. It is not enough to get a signed contract when the buyer's legal, security, and compliance teams are involved, and when the agent will touch production systems, financial records, or patient data.
The shift is not about trust in the abstract. It is about evidence: specific artifacts that answer specific questions. This article names the questions, explains why each one matters to the buyer, and describes the evidence that answers it. If you are building that evidence chain now, you are ahead. If you are retrofitting it during a stalled deal, this will tell you what to build first.
Why the buying motion changed
Demos work when the buyer is evaluating whether an agent can do the task at all. As of mid-2025, 57% of companies already had AI agents in production and 22% were in pilot, which means most enterprise buyers you talk to have already seen agents work in a demo. The question has moved from "can it do this?" to "can we depend on it?"
That shift happens because agents in production take actions with real consequences: they send emails, update records, approve transactions, generate documents that get filed. When something goes wrong, someone is accountable. Buyers at the procurement stage are trying to figure out whether that someone is them.
Vibes and testimonials stop working here because they do not transfer accountability. A reference customer saying "it's been great for us" does not tell the new buyer what the failure rate is, what happens when the agent does something unexpected, or whether there is a record they can show a regulator. Procurement teams are not being difficult when they ask for more. They are doing their job.
Gartner projected that 40% of enterprise applications would integrate task-specific AI agents by end of 2026, up from less than 5% in 2025. The buyers who are moving fast are the ones who already know what questions to ask.
The five questions buyers actually ask
"How do you know it did the right thing?"
This is the most common question, and it sounds simple until you try to answer it with evidence instead of reassurance.
"It did the right thing" requires a definition of right. For an agent processing prior authorization requests, right means the decision matches clinical criteria. For an agent drafting invoices, right means the amounts, payees, and terms are correct. The buyer wants to know that you have a definition, that you measure against it, and that the measurement has been running long enough to mean something.
The evidence artifact here is a task success metric tracked over time: not a single accuracy figure from an internal test, but a rate measured on real tasks in production, updated regularly, with a denominator you can explain. If your agent processed 10,000 tasks last month and succeeded on 9,720 of them, that is a number a buyer can evaluate. "It works really well" is not.
Cohere Health processes 12 million prior authorization requests annually with near-real-time decisions. That figure is credible not because it is large, but because it implies a measurement infrastructure. Buyers notice the difference between a vendor who can say "we processed X requests with Y outcome rate" and one who cannot.
Quality and risk scores at the individual task level strengthen this further. If you can show a buyer a distribution of scores across recent tasks, including the low-scoring ones and what happened to them, you are showing that your measurement is honest.
"What happens when it goes wrong?"
Every agent fails sometimes. Buyers know this. What they are actually asking is: does your system detect failure, and what does it do when it detects one?
The evidence here is an incident and termination record: a log of every time the agent was stopped, handed off to a human, or flagged for review, with a reason attached. This record serves two purposes. It shows the buyer that failure handling exists and runs automatically. It also gives them a base rate: over the last quarter, the agent was terminated or escalated X times out of Y total runs.
Intuit's agent products, which handle 50+ million transactions per week across accounting, tax, and payroll, maintained an 85% repeat usage rate partly by keeping humans in the loop at decision points where errors would be costly. Their public reporting on this is instructive: the metric they lead with is not accuracy, it is repeat usage, because repeat usage is downstream of users trusting the output. The implicit message is that failures were handled in a way that preserved confidence rather than destroying it.
If your agent has no termination records because it never terminates, that is itself a red flag to a careful buyer. It suggests the agent does not know when it is uncertain.
"Can you show me the failure rate?"
This is a more specific version of the previous question, and it deserves its own treatment because buyers often ask it after they have already heard a positive headline metric.
The failure rate question is asking for a denominator. A headline like "95% accuracy" is easy to question: 95% of what tasks, measured how, over what time window, on whose definition of correct? A buyer who has been through a bad AI vendor experience will probe exactly here.
The evidence that answers this is a combination of your task success metric (with denominator and methodology stated) and your quality scoring methodology published in enough detail that the buyer can evaluate whether it is measuring the right things. This does not need to be a whitepaper. A two-page methodology note explaining what inputs the scoring uses, what it does not cover, and what failure thresholds trigger escalation will do more work than a confidence interval on a graph.
See the problems we solve section for a more detailed breakdown of what measurement gaps tend to surface during procurement reviews.
"Who is accountable?"
This question has a legal dimension and a practical one. Legally, the buyer wants to know what your liability posture is if the agent causes a material error. Practically, they want to know who inside your company is responsible for agent quality and what that person actually does.
You cannot fully answer the legal question in a sales conversation, and you should not try. What you can answer is the practical one: here is how agent quality is monitored, here is who owns it, here is what they do when a quality metric drops.
The accountability evidence is an audit trail: a record of every action the agent took, every decision point, every input it received and output it produced, timestamped and queryable. This record is what allows a buyer to reconstruct what happened after an incident. Without it, accountability is a statement of intent. With it, accountability is a verifiable process.
AtlantiCare's deployment of Oracle's clinical AI agent across 260 providers and 26 specialties generating roughly 1,000 notes per day is an example where this audit question is load-bearing. Clinical documentation has direct patient safety implications. The ability to retrieve and review what the agent produced, and when, and based on what inputs, is not optional in that context.
Prefactor records a full span-level audit trail for every agent run, including tool calls, decisions, and outcomes, precisely because this is what enterprise buyers in regulated industries require before they will sign.
"Can we audit what it did?"
This is the audit trail question made explicit, and it comes up most often from legal, compliance, and security reviewers rather than from the product or engineering team.
The answer requires two things: the trail exists, and you can actually produce it in a usable format. A trail that exists but takes three weeks and a Jira ticket to extract is not an auditable system in any practical sense.
The evidence here is a demonstration: here is how you query the audit trail, here is what a record looks like, here is the access control model. If you have SOC 2 Type II certification, that is relevant context, since 80% of mid-market SaaS RFPs now require it. But the audit trail itself is a separate question from the certification. Certification tells the buyer your processes meet a standard. The trail tells them what the agent did on Tuesday.
Why retrofitting this during a stalled deal is hard
The evidence artifacts described above are not things you can produce quickly once a deal is moving. Task success metrics require historical data, which requires instrumentation that has been running. An audit trail requires that every action has been recorded since the agent went to production. Incident records require that incidents have been classified and stored, not just handled and forgotten.
The cost of retrofitting is not just engineering time. It is that you cannot show historical data you did not collect. A buyer asking for your ninety-day failure rate in month two of your enterprise sales process will get a number covering at most two months, and they will notice.
LangChain's State of Agent Engineering survey from late 2025 found that 89% of respondents had implemented some form of observability for their agents, with 62% having detailed tracing at the individual step level. Teams that instrumented early have this evidence available. Teams that did not are building it under pressure, with a shorter data window than the buyer wants.
The practical order of operations is: instrument before you ship to production, define your quality criteria before you have customers, and start generating task success metrics from day one. By the time you are in a serious enterprise conversation, you want six months of data, not six weeks.
You can see how we approach this instrumentation question on the learn page, and how it fits into a broader evaluation practice.
The evidence chain as a product decision
Building this evidence chain is not a compliance project that runs parallel to product development. It is a product decision about what your agent ships with.
An agent that ships with instrumentation, quality scoring, and an audit trail is a different product from one that does not. The difference shows up in enterprise deals, but it also shows up in how quickly you can debug production issues, how confidently you can make claims about performance, and whether you can answer a customer's question about what happened last Thursday without a manual investigation.
The buyers who ask these questions are not trying to slow your deal. They are trying to understand whether your agent is the kind of thing their organization can depend on. The evidence chain is your answer.
For a more detailed comparison of what different evaluation approaches cover and leave out, see the compare page.
Where to start
Instrument your agent before your next enterprise conversation, not after. Define your quality criteria in writing, set a task success metric with a real denominator, and make sure your audit trail is queryable without engineering involvement.
Start evaluating your agents or read the docs to see how Prefactor records spans, scores quality and risk, and generates the audit trail your buyers will ask for.